Tag: XCath
XCath secures US$30 million in Series C funding
XCath has secured US$30 million in Series C funding, bringing the total raised since the company’s inception to US$92 million, with these latest funds...
XCath performs first-in-human brain aneurysm procedures with endovascular robotic system
XCath has announced the successful first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms. These “landmark” procedures were...
XCath to incorporate NVIDIA’s Isaac for Healthcare into neurovascular robotic system
XCath has announced the incorporation of artificial intelligence (AI)-driven simulation, powered by NVIDIA's Isaac for Healthcare, into XCath’s autonomous robotic system, which is intended...
XCath successfully performs first public telerobotic mechanical thrombectomy demonstration
XCath has announced the successful completion of a “first-of-its-kind” live telerobotic trial for stroke treatment, which took place between Abu Dhabi, United Arab Emirates...
XCath highlights endovascular robotics innovation at SLICE Next Frontiers
XCath has announced that it presented at the recent Stroke Live Course (SLICE) Next Frontiers conference (3–4 April, virtual), hosted by Vincent Costalat (University Hospital...
